Literature DB >> 11027344

Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles.

S Chaudhuri1, A Cariappa, M Tang, D Bell, D A Haber, K J Isselbacher, D Finkelstein, D Forcione, S Pillai.   

Abstract

Tumors are believed to emerge only when immune surveillance fails. We wished to ascertain whether the failure to inherit putative protective alleles of HLA class II genes is linked to the development of breast cancer. We molecularly typed HLA DPB1, DQB1, DRB1, and DRB3 alleles in 176 Caucasian women diagnosed with early-onset breast cancer and in 215 ethnically matched controls. HLA DQB*03032 was identified in 7% of controls but in no patients with early-onset breast cancer (P = 0.0001). HLA DRB1*11 alleles were also significantly overrepresented (P < 0.0001) in controls (16. 3%) as compared with patients with early-onset breast cancer (3.5%). HLA DQB*03032 and HLA DRB1*11 alleles may have a protective role in human breast cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027344      PMCID: PMC17220          DOI: 10.1073/pnas.97.21.11451

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

Authors:  F M Marincola; E M Jaffee; D J Hicklin; S Ferrone
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

2.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

3.  Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region.

Authors:  S J Lu; N E Day; L Degos; V Lepage; P C Wang; S H Chan; M Simons; B McKnight; D Easton; Y Zeng
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

4.  Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.

Authors:  M Krainer; S Silva-Arrieta; M G FitzGerald; A Shimada; C Ishioka; R Kanamaru; D J MacDonald; H Unsal; D M Finkelstein; A Bowcock; K J Isselbacher; D A Haber
Journal:  N Engl J Med       Date:  1997-05-15       Impact factor: 91.245

5.  Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease.

Authors:  A Cariappa; B Sands; D Forcione; D Finkelstein; D K Podolsky; S Pillai
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

6.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

7.  HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.

Authors:  R J Apple; H A Erlich; W Klitz; M M Manos; T M Becker; C M Wheeler
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

Review 8.  Tumor antigens recognized by T lymphocytes.

Authors:  T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

9.  A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.

Authors:  T Wölfel; M Hauer; J Schneider; M Serrano; C Wölfel; E Klehmann-Hieb; E De Plaen; T Hankeln; K H Meyer zum Büschenfelde; D Beach
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

10.  A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Authors:  P G Coulie; V Brichard; A Van Pel; T Wölfel; J Schneider; C Traversari; S Mattei; E De Plaen; C Lurquin; J P Szikora; J C Renauld; T Boon
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  28 in total

1.  Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.

Authors:  Bryan A Bassig; Peter D Inskip; Laurie Burdette; William R Shapiro; Robert G Selker; Howard A Fine; Jay S Loeffler; Peter M Black; Robert Dubrow; Alina V Brenner
Journal:  J Neuroimmunol       Date:  2010-12-30       Impact factor: 3.478

2.  CAGE: Combinatorial Analysis of Gene-cluster Evolution.

Authors:  Giltae Song; Louxin Zhang; Tomas Vinar; Webb Miller
Journal:  J Comput Biol       Date:  2010-09       Impact factor: 1.479

3.  HLA class II polymorphism: protective or risk factors to breast cancer in Tunisia?

Authors:  Amal Baccar Harrath; Besma Yacoubi Loueslati; Wafa Troudi; Slama Hmida; Syrine Sedkaoui; Amel Dridi; Afef Jridi; Farhat Ben Ayed; Khaled Ben Rhomdhane; Amel Ben Ammar Elgaaied
Journal:  Pathol Oncol Res       Date:  2006-06-24       Impact factor: 3.201

4.  HLA-DRB1,-DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer.

Authors:  Majid Mahmoodi; Hedayat Nahvi; Mahdi Mahmoudi; Amir Kasaian; Mohammad-Ali Mohagheghi; Kouros Divsalar; Bijan Nahavandian; Abbas Jafari; Bita Ansarpour; Batoul Moradi; Asghar Aghamohammadi; Aliakbar Amirzargar
Journal:  Pathol Oncol Res       Date:  2011-07-01       Impact factor: 3.201

5.  A Genome-Wide Association Study Identifies Two Novel Susceptible Regions for Squamous Cell Carcinoma of the Head and Neck.

Authors:  Hongliang Liu; Jian Wang; Robert Yu; Sanjay Shete; Erich M Sturgis; Guojun Li; Kristina R Dahlstrom; Zhensheng Liu; Christopher I Amos; Qingyi Wei
Journal:  Cancer Res       Date:  2020-04-10       Impact factor: 12.701

6.  HLA class-II allele frequencies in Turkish breast cancer patients.

Authors:  Faik Deniz Gun; Ozlem Goruroglu Ozturk; Ayse Polat; Gurbuz Polat
Journal:  Med Oncol       Date:  2011-03-04       Impact factor: 3.064

7.  Two HLA Class II Gene Variants Are Independently Associated with Pediatric Osteosarcoma Risk.

Authors:  Chenan Zhang; Joseph L Wiemels; Helen M Hansen; Julio Gonzalez-Maya; Alyson A Endicott; Adam J de Smith; Ivan V Smirnov; John S Witte; Libby M Morimoto; Catherine Metayer; Kyle M Walsh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-23       Impact factor: 4.254

Review 8.  Tumor vaccines for breast cancer.

Authors:  Karen S Anderson
Journal:  Cancer Invest       Date:  2009-05       Impact factor: 2.176

9.  Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer.

Authors:  Karen S Anderson; Niroshan Ramachandran; Jessica Wong; Jacob V Raphael; Eugenie Hainsworth; Gokhan Demirkan; Daniel Cramer; Dina Aronzon; F Stephen Hodi; Lyndsay Harris; Tanya Logvinenko; Joshua LaBaer
Journal:  J Proteome Res       Date:  2008-02-27       Impact factor: 4.466

10.  High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study.

Authors:  David Cantú de León; Delia Pérez-Montiel; Verónica Villavicencio; Alejandro García Carranca; Alejandro Mohar Betancourt; Victor Acuña-Alonzo; Alberto López-Tello; Gilberto Vargas-Alarcón; Rodrigo Barquera; Neng Yu; Edmond J Yunis; Julio Granados
Journal:  BMC Cancer       Date:  2009-02-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.